Abstract
Summary: The interpretation of CEA levels in patients with malignant disease is still difficult in some instances because of lack of knowledge of the factors which influence the concentrations of CEA in peripheral blood. In the present study of patients with advanced ovarian cancer, CEA was measured in extracts of the tumour, in cyst fluid, in ascitic fluid, as well as in serum. A gradient in CEA level was found in the various compartments, highest values being found in the primary tumour and cyst fluid, intermediate values in the surrounding ascitic fluid, and the lowest values in peripheral blood. A significant correlation was found between CEA concentrations in tumour and cyst fluid or ascitic fluid, but not between CEA concentrations in tumour and serum. CEA was more frequently detected in the ascitic fluid than the corresponding serum; it increased the CEA positivity rate from 57% to 78%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Australian & New Zealand journal of obstetrics & gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
